(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DIASORIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DIASORIN

ST13

US500000075574121

Class

1, 5, 10

Filing

75574121

Registration

2403277

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

02/22/2021

Trademark type

Combined

Nice classes

1, 5, 10

Filing date

10/15/1998

Registration date

11/14/2000

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/22/2021

Last transaction

02/22/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

07/07/1998

First use in commerce

07/07/1998

Drawing code

3

Owner type

03

Owner location

Saluggia (Vercelli), IT

Examiner

BUTLER, ALPHONZO

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

DiaSorin S.p.A.
DiaSorin International Inc.

Representatives

Jeffrey B. Sladkus, Esq. The Sladkus Law Group

Technical classification

Nice Classes

Class 1Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations and reagents for research and scientific use; reagents and raw materials used in research and development of in vitro medical diagnostic apparatus

Class 5

Medical diagnostic reagents and raw materials for in vitro use in testing laboratories

Class 10

in vitro medical diagnostic apparatus

Publications

History of USPTO decisions and trademark events.

23 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/22/2021

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

02/22/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/22/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/22/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

11/16/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/14/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/16/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/16/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

11/10/2010

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

01/23/2009

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/23/2006

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/23/2006

CFIT

CASE FILE IN TICRS

08/03/2006

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/28/2006

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

03/30/2006

E815

TEAS SECTION 8 & 15 RECEIVED

03/30/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

11/14/2000

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/18/1999

PUBO

PUBLISHED FOR OPPOSITION

11/02/1999

NPUB

NOTICE OF PUBLICATION

10/01/1999

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/1999

CNEA

EXAMINER'S AMENDMENT MAILED

06/21/1999

DOCK

ASSIGNED TO EXAMINER

05/13/1999

Continuous trademark protection

Get notified about every new filing that threatens DIASORIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.